ACOG (American College of Obstetricians and Gynecologists). 2015. Committee opinion no. 640: Cell-free DNA screening for fetal aneuploidy. Obstetrics and Gynecology 126(3):e31–e37.
AHRQ (Agency for Healthcare Research and Quality). 2015. 2014 National healthcare quality and disparities report. http://www.ahrq.gov/sites/default/files/wysiwyg/research/findings/nhqrdr/nhqdr14/2014nhqdr.pdf (accessed February 26, 2016).
Allyse, M. A., L. C. Sayres, M. Havard, J. S. King, H. T. Greely, L. Hudgins, J. Taylor, M. E. Norton, M. K. Cho, D. Magnus, and K. E. Ormond. 2013. Best ethical practices for clinicians and laboratories in the provision of noninvasive prenatal testing. Prenatal Diagnosis 33(7):656–661.
Awadalla, P., C. Boileau, Y. Payette, Y. Idaghdour, J. P. Goulet, B. Knoppers, P. Hamet, C. Laberge, and C. A. Project. 2013. Cohort profile of the CARTaGENE study: Québec’s population-based biobank for public health and personalized genomics. International Journal of Epidemiology 42(5):1285–1299.
Balas, E. A., and S. A. Boren. 2000. Managing clinical knowledge for health care improvement. Yearbook of Medical Informatics 65–70.
Bianchi, D. W. 2015. Pregnancy: Prepare for unexpected prenatal test results. Nature 522(7554):29–30.
Bianchi, D. W., D. Chudova, A. J. Sehnert, S. Bhatt, K. Murray, T. L. Prosen, J. E. Garber, L. Wilkins-Haug, N. L. Vora, S. Warsof, J. Goldberg, T. Ziainia, and M. Halks-Miller. 2015. Noninvasive prenatal testing and incidental detection of occult maternal malignancies. JAMA 314(2):162–169.
Borugian, M. J., P. Robson, I. Fortier, L. Parker, J. McLaughlin, B. M. Knoppers, K. Bedard, R. P. Gallagher, S. Sinclair, V. Ferretti, H. Whelan, D. Hoskin, and J. D. Potter. 2010. The Canadian partnership for tomorrow project: Building a pan-Canadian research platform for disease prevention. Canadian Medical Association Journal 182(11):1197–1201.
Campeau, P. M., W. D. Foulkes, and M. D. Tischkowitz. 2008. Hereditary breast cancer: New genetic developments, new therapeutic avenues. Human Genetics 124(1):31–42.
Coram, M. A., S. I. Candille, Q. Duan, K. H. Chan, Y. Li, C. Kooperberg, A. P. Reiner, and H. Tang. 2015. Leveraging multi-ethnic evidence for mapping complex traits in minority populations: An empirical Bayes approach. American Journal of Human Genetics 96(5):740–752.
Curran, G. M., M. Bauer, B. Mittman, J. M. Pyne, and C. Stetler. 2012. Effectiveness–implementation hybrid designs: Combining elements of clinical effectiveness and implementation research to enhance public health impact. Medical Care 50(3):217–226.
Damschroder, L. J., D. C. Aron, R. E. Keith, S. R. Kirsh, J. A. Alexander, and J. C. Lowery. 2009. Fostering implementation of health services research findings into practice: A consolidated framework for advancing implementation science. Implementation Science 4:50.
Dotson, W. D., M. P. Douglas, K. Kolor, A. C. Stewart, M. S. Bowen, M. Gwinn, A. Wulf, H. M. Anders, C. Q. Chang, M. Clyne, T. K. Lam, S. D. Schully, M. Marrone, W. G. Feero, and M. J. Khoury. 2014. Prioritizing genomic applications for action by level of evidence: A horizon-scanning method. Clinical Pharmacology and Therapeutics 95(4):394–402.
EGAPP (Evaluation of Genomic Applications in Practice and Prevention) Working Group. 2009. Recommendations from the EGAPP Working Group: Genetic testing strategies in newly diagnosed individuals with colorectal cancer aimed at reducing morbidity and mortality from Lynch syndrome in relatives. Genetics in Medicine 11(1):35–41.
Glasgow, R. E., E. Lichtenstein, and A. C. Marcus. 2003. Why don’t we see more translation of health promotion research to practice? Rethinking the efficacy-to-effectiveness transition. American Journal of Public Health 93(8):1261–1267.
Green, E. D., and M. S. Guyer. 2011. Charting a course for genomic medicine from base pairs to bedside. Nature 470(7333):204–213.
Green, R. C., J. S. Berg, W. W. Grody, S. S. Kalia, B. R. Korf, C. L. Martin, A. L. McGuire, R. L. Nussbaum, J. M. O’Daniel, K. E. Ormond, H. L. Rehm, M. S. Watson, M. S. Williams, L. G. Biesecker, and the American College of Medical Genetics and Genomics. 2013. ACMG recommendations for reporting of incidental findings in clinical exome and genome sequencing. Genetics in Medicine 15(7):565–574.
Green, R. F., W. D. Dotson, S. Bowen, K. Kolor, and M. J. Khoury. 2015. Genomics in public health: Perspective from the Office of Public Health Genomics at the Centers for Disease Control and Prevention (CDC). Healthcare (Basel) 3(3):830–837.
Greenhalgh, T., G. Robert, F. Macfarlane, P. Bate, and O. Kyriakidou. 2004. Diffusion of innovations in service organizations: Systematic review and recommendations. Milbank Quarterly 82(4):581–629.
Haga, S. B. 2010. Impact of limited population diversity of genome-wide association studies. Genetics in Medicine 12(2):81–84.
Hurle, B., T. Citrin, J. F. Jenkins, K. A. Kaphingst, N. Lamb, J. E. Roseman, and V. L. Bonham. 2013. What does it mean to be genomically literate?: National Human Genome Research Institute meeting report. Genetics in Medicine 15(8):658–663.
IOM (Institute of Medicine). 2009. Initial national priorities for comparative effectiveness research. Washington, DC: The National Academies Press.
Joosten, Y. A., T. L. Israel, N. A. Williams, L. R. Boone, D. G. Schlundt, C. P. Mouton, R. S. Dittus, G. R. Bernard, and C. H. Wilkins. 2015. Community engagement studios: A structured approach to obtaining meaningful input from stakeholders to inform research. Academic Medicine 90(12):1646–1650.
Kaimal, A. J., M. E. Norton, and M. Kuppermann. 2015. Prenatal testing in the genomic age: Clinical outcomes, quality of life, and costs. Obstetrics and Gynecology 126(4):737–746.
Kim, E. S., D. Bernstein, S. G. Hilsenbeck, C. H. Chung, A. P. Dicker, J. L. Ersek, S. Stein, F. R. Khuri, E. Burgess, K. Hunt, P. Ivy, S. S. Bruinooge, N. Meropol, and R. L. Schilsky. 2015. Modernizing eligibility criteria for molecularly driven trials. Journal of Clinical Oncology 33(25):2815–2820.
Knerr, S., D. Wayman, and V. L. Bonham. 2011. Inclusion of racial and ethnic minorities in genetic research: Advance the spirit by changing the rules? Journal of Law, Medicine, and Ethics 39(3):502–512.
Lomas, J. 1993. Diffusion, dissemination, and implementation: Who should do what? Annals of the New York Academy of Sciences 703:226–235; discussion 235–237.
Madon, T., K. J. Hofman, L. Kupfer, and R. I. Glass. 2007. Public health. Implementation science. Science 318(5857):1728–1729.
Manolio, T. A., R. L. Chisholm, B. Ozenberger, D. M. Roden, M. S. Williams, R. Wilson, D. Bick, E. P. Bottinger, M. H. Brilliant, C. Eng, K. A. Frazer, B. Korf, D. H. Ledbetter, J. R. Lupski, C. Marsh, D. Mrazek, M. F. Murray, P. H. O’Donnell, D. J. Rader, M. V. Relling, A. R. Shuldiner, D. Valle, R. Weinshilboum, E. D. Green, and G. S. Ginsburg. 2013. Implementing genomic medicine in the clinic: The future is here. Genetics in Medicine 15(4):258–267.
Michigan Cancer Consortium. 2014. Comprehensive cancer control plan for Michigan 2009–2015: Mapping a course for excellence in Michigan.ftp://ftp.cdc.gov/pub/Publications/Cancer/ccc/michigan_ccc_plan.pdf (accessed March 7, 2016).
Michigan Department of Community Health. 2004. Genetics through the life cycle: Improving health and preventing disease. Lansing, MI: Michigan Department of Community Health. http://www.michigan.gov/documents/MIgeneticsplanandassessment__118168_7.pdf (accessed April 13, 2016).
National Diabetes Information Clearinghouse. 2007. Monogenic forms of diabetes: Neonatal diabetes mellitus and maturity-onset diabetes of the young. National Institute of Diabetes and Digestive and Kidney Diseases. http://www.niddk.nih.gov/health-information/health-topics/Diabetes/monogenic-forms-diabetes-neonatal-diabetes-mellitus-maturity-onset-diabetes-young/Pages/index.aspx (accessed March 7, 2016).
NHGRI (National Human Genome Research Institute). 2016. NHGRI develops path forward to address health disparities. https://www.genome.gov/27563541 (accessed February 26, 2016).
NIH (National Institutes of Health). 2016. Implementation science information and resources. http://www.fic.nih.gov/aresearchtopics/pages/implementationscience.aspx (accessed February 26, 2016).
Office of Public Health Strategy and Analysis, Office of the Commissioner. Food and Drug Administration. 2015. The public health evidence for FDA oversight of laboratory developed tests: 20 case studies. http://www/fda.gov/downloads/AboutFDA/ReportsManualsForms/Reports//UCM472777.pdf (accessed March 7, 2016).
Pihoker, C., L. K. Gilliam, S. Ellard, D. Dabelea, C. Davis, L. M. Dolan, C. J. Greenbaum, G. Imperatore, J. M. Lawrence, S. M. Marcovina, E. Mayer-Davis, B. L. Rodriguez, A. K. Steck, D. E. Williams, A. T. Hattersley, and Search for Diabetes in Youth Study Group. 2013. Prevalence, characteristics and clinical diagnosis of maturity onset diabetes of the young due to mutations in HNF1A, HNF4A, and glucokinase: Results from the search for diabetes in youth. Journal of Clinical Endocrinology and Metabolism 98(10):4055–4062.
Pletcher, B. A., H. V. Toriello, S. J. Noblin, L. H. Seaver, D. A. Driscoll, R. L. Bennett, and S. J. Gross. 2007. Indications for genetic referral: A guide for healthcare providers. Genetics in Medicine 9(6):385–389.
Sahoo, S. S., S. Tao, A. Parchman, Z. Luo, L. Cui, P. Mergler, R. Lanese, J. S. Barnholtz-Sloan, N. J. Meropol, and G. Q. Zhang. 2014. Trial prospector: Matching patients with cancer research studies using an automated and scalable approach. Cancer Informatics 13:157–166.
Scheuner, M. T., A. B. Hamilton, J. Peredo, T. J. Sale, C. Austin, S. C. Gilman, M. S. Bowen, C. L. Goldzweig, M. Lee, B. S. Mittman, and E. M. Yano. 2014. A cancer genetics toolkit improves access to genetic services through documentation and use of the family history by primary-care clinicians. Genetics in Medicine 16(1):60–69.
Schilsky, R. L. 2014. Implementing personalized cancer care. Nature Reviews Clinical Oncology 11(7):432–438.
Shepherd, M., B. Shields, S. Ellard, O. Rubio-Cabezas, and A. T. Hattersley. 2009. A genetic diagnosis of HNF1A diabetes alters treatment and improves glycaemic control in the majority of insulin-treated patients. Diabetic Medicine 26(4):437–441.
Shields, A. E., W. Burke, and D. E. Levy. 2008. Differential use of available genetic tests among primary care physicians in the United States: Results of a national survey. Genetics in Medicine 10(6):404–414.
Teutsch, S. M., L. A. Bradley, G. E. Palomaki, J. E. Haddow, M. Piper, N. Calonge, W. D. Dotson, M. P. Douglas, A. O. Berg, and the EGAPP Working Group. 2009. The EGAPP initiative: Methods of the EGAPP working group. Genetics in Medicine 11(1):3–14.
Wang, G., M. S. Beattie, N. A. Ponce, and K. A. Phillips. 2011. Eligibility criteria in private and public coverage policies for BRCA genetic testing and genetic counseling. Genetics in Medicine 13(12):1045–1050.
Wang, J. C., T. Sahoo, S. Schonberg, K. A. Kopita, L. Ross, K. Patek, and C. M. Strom. 2015. Discordant noninvasive prenatal testing and cytogenetic results: A study of 109 consecutive cases. Genetics in Medicine 17(3):234–236.
WHO (World Health Organization). 2014. Implementation research toolkit: Participants manual. Original edition, March 27, 2014. http://www.who.int/tdr/publications/year/2014/9789241506960_workbook_eng.pdf?ua=1 (accessed March 7, 2016).
This page intentionally left blank.